Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis

Figure 4 Quantitative analysis for hepatocyte specific protein expression by biochemical analysis to compare the liver fibrosis treatment efficacy of intravenous, intrahepatic and intraperitoneal mesenchymal stem cell injection. Non-treated carbon tetrachloride (CCl4) group acted as normal control. Rats not injected with mesenchymal stem cells (MSCs) after CCl4 processing were used as sham control. Data represent the mean ± SE, and ^aP < 0.05. A: Analysis for albumin expression; B: Analysis for total bilirubin in serum (TBIL) expression; C: Analysis for alanine aminotransferase (ALT) expression.